Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Avantor, Inc. (AVTR)
Sector: Basic Materials; Industry: Specialty Chemicals

Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-10-01 GUPTA RAJIV Director Sell 100,000 $39.94 $3,994,000 No
2021-08-26 Eck Steven W SVP & Chief Accounting Officer Sell 17,383 $40.08 $696,711 No
2021-07-12 Natauri Jo Director Buy 300 $36.33 $10,900 No
2021-07-09 Bramwell James EVP, Strategic Partners Sell 18,331 $35.61 $652,828 No
2021-06-28 Couturier Christophe EVP, AMEA Sell 28,096 $35.73 $1,003,870 No
2021-06-25 GUPTA RAJIV Director Sell 68,605 $35.32 $2,423,129 No
2021-06-10 Stubblefield Michael President and CEO Sell 487,700 $32.13 $15,667,507 Yes
2021-05-27 Ohri Devashish EVP, IMEA Sell 100,000 $31.99 $3,199,000 Yes
2021-05-24 GUPTA RAJIV Director Sell 337,571 $31.66 $10,687,716 No
2021-05-24 Ohri Devashish EVP, IMEA Sell 9,124 $31.75 $289,687 Yes
2021-05-20 Miller Justin EVP & General Counsel Sell 18,488 $31.12 $575,347 No
2021-05-20 Couturier Christophe EVP, AMEA Sell 25,010 $31.13 $778,561 No
2021-05-20 Brophy Gerard EVP, Biopharma Production Sell 19,603 $31.10 $609,653 No
2021-05-11 Natauri Jo Director Sell 2,626,771 $30.68 $80,589,334 No
2019-09-25 Natauri Jo Director Sell 950 $14.00 $13,300 No
2019-09-25 GOLDMAN SACHS & CO. LLC 10%-Owner Sell 950 $14.00 $13,300 No
2019-09-25 Connolly Thomas Director Sell 950 $14.00 $13,300 Yes
2021-04-30 Ohri Devashish EVP, IMEA Sell 53,649 $32.58 $1,747,884 Yes
2021-04-12 Ohri Devashish EVP, IMEA Sell 100,160 $32.37 $3,242,179 Yes
2021-04-12 Vanderhaegen Frederic EVP, Europe Sell 27,075 $31.80 $860,997 No
2021-04-12 Bramwell James EVP, Strategic Partners Sell 2,505 $32.00 $80,160 No
2021-04-12 Miller Justin EVP & General Counsel Sell 102,895 $33.17 $3,412,916 Yes
2021-03-09 Vanderhaegen Frederic EVP, Europe Sell 10,000 $28.21 $282,100 No
2021-03-02 Wondrasch Michael EVP & CIO Sell 3,036 $28.71 $87,164 No
2021-02-24 Brophy Gerard EVP, Biopharma Production Sell 3,059 $27.93 $85,438 No
2021-02-22 Brophy Gerard EVP, Biopharma Production Sell 19,769 $28.62 $565,789 Yes
2021-02-05 Wondrasch Michael EVP & CIO Sell 49,468 $29.77 $1,472,662 Yes
2021-01-11 Bramwell James EVP, Strategic Partners Sell 2,505 $30.00 $75,150 No
2021-01-11 Brophy Gerard EVP, Biopharma Production Sell 378,580 $30.06 $11,381,196 Yes
2021-01-06 Brophy Gerard EVP, Biopharma Production Sell 11,509 $27.24 $313,505 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.